Description
As bariatric surgeons, we have a pivotal role in the overall health of patients with obesity. We commonly screen for many obesity-related conditions, such as obstructive sleep apnea, which most primary care physicians don’t have the time or awareness to address. Similarly, NASH/NALFD (now called MASLD or Metabolic Dysfunction-Associated Steatotic Liver Disease) is a ‘sneaky’ condition, where routine imaging and bloodwork can miss even advanced disease. Intraoperative biopsies are simple to perform, and a tissue diagnosis can positively influence the trajectory of the patient’s postoperative lifespan and healthspan. Session question – should bariatric surgeons be more proactively involved in liver health of our patients?
Learning Objectives
- Appreciate the etiology and prevalence of NASH/NAFLD/MASLD and current treatments.
- Understand the role of bariatric surgery in managing this disease process.
- Gain familiarity with preoperative, intraoperative, and postoperative considerations for patients with Steatotic Liver Disease.
| 3:45pm |
Introduction Vance Albaugh, MD PhD; Laura Doyon, MD; Michel Murr, MD; Andres Sanchez-Pernaute, MD/PhD |
| 3:47pm |
Polling |
| 3:57pm |
State of NASH/NAFLD in US (abroad) Monica Tincopa |
| 4:06pm |
Preop EGD/EUS + sheerwave elastography |
| 4:15pm |
Intraoperative wedge biopsy; video. Laura Doyon, MD; Vance Albaugh, MD PhD |
| 4:24pm |
Postop management (ie now what do I do with my biopsy? Monica Tincopa |
| 4:33pm |
Liver transplant: Before and after bariatric surgery? Satish Nadig, MD PhD |
| 4:42pm |
Video potpourri – Practical tips on operating with Fatty/Cirrhotic “nightmare livers” Rana C Pullatt, MD |
| 4:51pm |
Conclusions Michel Murr, MD |
| 5:00pm |
Polling |
| 5:10pm |
Question and Answer |
| 5:15pm | Adjourn |